KCL-286

• Description:

  KCL-286 is an orally available and potent retinoic acid receptor beta agonist for the amelioration of spinal cord injury (SCI) .

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  334.33

• Molecular Formula:

  C19H14N2O4

• Notes:

  Research use only, not for human use.

• Receptor:

  Retinoid Receptor

• CAS Number:

  1952276-71-9